Zealand Pharma A/S
Zealand Pharma's GHG Emissions Data Preview
In 2024, Zealand Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Zealand Pharma has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Zealand Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Zealand Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Zealand Pharma's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Zealand Pharma amounted to 162 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Zealand Pharma decreased by 19%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Zealand Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Zealand Pharma's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Zealand Pharma were 145 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2023), Zealand Pharma's Scope 1 emissions remained relatively stable, indicating that Zealand Pharma's emissions have plateaued with no significant change in its operational footprint. a
What are Zealand Pharma's Scope 2 emissions?
In 2024, Zealand Pharma reported Scope 2 greenhouse gas (GHG) emissions of 0 tCO₂e using the market-based method and 17 tCO₂e using the location-based method. a
Has Zealand Pharma reduced its Scope 2 emissions over time?
Compared to the previous year (2023), Zealand Pharma's Scope 2 emissions (Location-Based) fell by 69.64% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a
What methodology does Zealand Pharma use for Scope 2 reporting?
In 2024, Zealand Pharma reported its Scope 2 emissions using the market-based method and using the location-based method. a
Zealand Pharma's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Zealand Pharma's Value Chain Emissions
In 2024, Zealand Pharma reported 266,412 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Zealand Pharma includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Zealand Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Zealand Pharma's Scope 3 emissions?
In 2024, Zealand Pharma reported total Scope 3 emissions of 266,412 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 16.86% of these emissions originated from upstream activities such as purchased goods and capital goods, while 83.14% came from downstream activities like product use, distribution, and end-of-life treatment. a
Compared to the previous year (2023), Zealand Pharma's Scope 3 emissions increased by 261.2%, suggesting that the company faced challenges in reducing emissions across its value chain. a
What categories of Scope 3 emissions does Zealand Pharma disclose?
In 2024, Zealand Pharma reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Zealand Pharma's Scope 3 emissions?
In 2024, the largest contributors to Zealand Pharma's Scope 3 emissions were: a
- Investments (Cat. 15): 221,492 tCO₂e (83.14%)
- Purchased Goods and Services (Cat. 1): 42,712 tCO₂e (16.03%)
- Business Travel (Cat. 6): 577 tCO₂e (0.22%)
Zealand Pharma's Scope 3 Emissions by Categories
Insights into Zealand Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Zealand Pharma reported Scope 1 greenhouse gas (GHG) emissions of 145 tCO₂e and total revenues of USD 9 millions. This translates into an emissions intensity of 16.6 tCO₂e per millions USD. a
Zealand Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Zealand Pharma's GHG emissions intensity compare to its peers?
In 2024, Zealand Pharma reported a Scope 1 emissions intensity of 16.6 tCO₂e per millions USD. Compared to the peer group median of 2.73 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Zealand Pharma rank on GHG emissions intensity within its industry?
In 2024, Zealand Pharma ranked 21 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Zealand Pharma among the least efficient performers, with one of the highest emissions intensities in its sector. a
Insights into Zealand Pharma's Total Carbon Footprint
In 2024, Zealand Pharma reported a total carbon footprint of 266,574 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 260.44% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Zealand Pharma's total carbon footprint was Scope 3 emissions, accounting for 99.94% of the company's total carbon footprint, followed by Scope 1 emissions at 0.05%. a